Beranda2AB • FRA
add
Barinthus Biotherapeutics PLC - ADR
Tutup sebelumnya
€0,48
Rentang tahun
€0,45 - €1,54
Kapitalisasi pasar
24,26Â jt USD
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 4,51Â jt | 180,64% |
Penghasilan bersih | -11,09Â jt | 46,01% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,27 | -33,70% |
EBITDA | -4,57Â jt | -336,68% |
Tarif pajak efektif | 0,51% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 70,46Â jt | -36,33% |
Total aset | 98,17Â jt | -38,77% |
Total liabilitas | 23,88Â jt | -20,92% |
Total ekuitas | 74,29 jt | — |
Saham yang beredar | 40,85 jt | — |
Harga terhadap nilai buku | 0,26 | — |
Tingkat pengembalian aset | -11,77% | — |
Tingkat pengembalian modal | -13,43% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -11,09Â jt | 46,01% |
Kas dari operasi | -4,24Â jt | -132,42% |
Kas dari investasi | 2,00Â rb | 100,72% |
Kas dari pembiayaan | 0,00 | -100,00% |
Perubahan kas bersih | -3,82Â jt | -160,69% |
Arus kas bebas | 2,94Â jt | -80,40% |
Tentang
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Didirikan
2016
Situs
Karyawan
14
